08
October 2024
Past Event
Do Drug Patents Cause High Drug Prices?

Event will air on this page.

 

Inquiries: msnow@hudson.org

Do Drug Patents Cause High Drug Prices?

Past Event
Online Only
October 08, 2024
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
Caption
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
08
October 2024
Past Event

Event will air on this page.

 

Inquiries: msnow@hudson.org

Speakers:
Adam Mossoff
Adam Mossoff

Chair, Forum for Intellectual Property and Senior Fellow

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law
Erika Lietzan

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Vice President and Global Head of Intellectual Property Affairs, Novartis
Corey A. Salsberg

Vice President and Global Head of Intellectual Property Affairs, Novartis

Moderator:
hartline
Devlin Hartline

Senior Fellow

For the past decade, policy activists have argued that drug innovators artificially extend the length of their exclusive patent protections on their drugs solely to keep drug prices high. One activist organization, the Initiative for Medicines, Access, and Knowledge (I-MAK), alleges that as many as 50 patents currently protect drugs from generic competition. 

But are I-MAK’s patent numbers correct? A 2022 Hudson policy memo, “How Unreliable Data Has Infected the Policy Debate Over Drug Patents,”detailed how I-MAK’s patent numbers contradict the number of drug patents listed in the Orange Book, the Food and Drug Administration’s official database of drug patents. Academic scholars have also done rigorous empirical studies, and the United States Patent and Trademark Office (USPTO) released its own empirical study in June 2024. Neither the USPTO nor the academic studies could replicate or confirm activist organizations’ patent numbers. Yet I-MAK’s claims continue to drive legislative proposals and agency actions.

Join Hudson for an expert discussion on the state of play concerning the empirical evidence on the connection between drug patents and drug prices and whether officials are engaging in evidence-based policymaking on this pressing concern.

Related Events
23
June 2025
In-Person Event | Hudson Institute
An Afrikaner Perspective on US–South Africa Relations
Featured Speakers:
Dr. Corné Mulder
Dr. Theo de Jager
Mr. Gerhard Papenfus
Moderator:
Joshua Meservey
Getty Images
23
June 2025
In-Person Event | Hudson Institute
An Afrikaner Perspective on US–South Africa Relations

Three leaders of prominent South African organizations with strong Afrikaner memberships sit down with Hudson's Josh Meservey discuss the key issues roiling ties between Washington and Pretoria.

Getty Images
Featured Speakers:
Dr. Corné Mulder
Dr. Theo de Jager
Mr. Gerhard Papenfus
Moderator:
Joshua Meservey
24
June 2025
Virtual Event | Online Only
NATO Public Forum 2025
Getty Images
24
June 2025
Virtual Event | Online Only
NATO Public Forum 2025

As an institutional partner to the 2025 NATO Public Forum, Hudson Institute supports this key platform for dialogue alongside the NATO summit in The Hague.

Getty Images
24
June 2025
In-Person Event | Hudson Institute
The Need for Speed: Transforming Defense Procurement for a Dangerous World
Featured Speakers:
Congressman Mike Rogers
Congressman Adam Smith
Dan Patt
Bryan Clark
DVIDS
24
June 2025
In-Person Event | Hudson Institute
The Need for Speed: Transforming Defense Procurement for a Dangerous World

Join Hudson Senior Fellows Bryan Clark and Dan Patt for a discussion with Chairman Rogers and Ranking Member Smith about the SPEED Act and why fixing defense acquisition and reviving the defense industrial base are essential to meeting America’s national security challenges.

DVIDS
Featured Speakers:
Congressman Mike Rogers
Congressman Adam Smith
Dan Patt
Bryan Clark
24
June 2025
In-Person Event | Hudson Institute
Investing in Africa
Featured Speakers:
Matthew Davis
Eliot Pence
Kurt Scherer
Moderator:
Joshua Meservey
Getty Images
24
June 2025
In-Person Event | Hudson Institute
Investing in Africa

Hudson’s Joshua Meservey will host a panel of investors with decades of collective experience in Africa. 

Getty Images
Featured Speakers:
Matthew Davis
Eliot Pence
Kurt Scherer
Moderator:
Joshua Meservey